NFKB1 and hepatocellular carcinoma: Furthermore, 96 can markedly inhibit LPS or TNF-α-induced activation of NF-κB through both inhibiting the phosphorylation of IκBα and p65 and preventing the P65 nuclear translocation to exhibit anti-hepatoma and anti-inflammatory activities.